Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TNF superfamily control of tissue remodeling and fibrosis. | Front Immunol | 2023 | 37465675 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma. | Front Immunol | 2023 | 37465666 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma. | Front Immunol | 2023 | 37457709 | PubTator, text mining | PubMed |
| The latest breakthrough on genetic characteristics of inflammatory bowel disease in Chinese and other East Asian ancestries. | Precis Clin Med | 2023 | 37456986 | PubTator, text mining | PubMed |
| A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma. | PeerJ | 2023 | 37456890 | PubTator, text mining | PubMed |
| An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis. | BMC Pediatr | 2023 | 37454049 | PubTator, text mining | PubMed |
| GATA3 induces the pathogenicity of Th17 cells via regulating GM-CSF expression. | Front Immunol | 2023 | 37449212 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Diagnosis of post-neurosurgical bacterial meningitis in patients with aneurysmal subarachnoid hemorrhage based on the immunity-related proteomics signature of the cerebrospinal fluid. | Front Neurol | 2023 | 37409018 | PubTator, text mining | PubMed |
| LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment. | Mol Ther | 2023 | 37408308 | PubTator, text mining | PubMed |
| Antibody responses to dietary antigens are accompanied by specific plasma cells in the infant thymus. | J Allergy Clin Immunol | 2023 | 37406823 | PubTator, text mining | PubMed |
| Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. | PLoS One | 2023 | 37405988 | PubTator, text mining | PubMed |
| Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer. | Front Oncol | 2023 | 37404757 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. | BMC Bioinformatics | 2023 | 37403043 | PubTator, text mining | PubMed |
| Glucose-dependent inflammatory responses in obese compared to lean individuals. | Endocrine | 2023 | 37400734 | PubTator, text mining | PubMed |
| Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19. | Front Pharmacol | 2023 | 37397483 | PubTator, text mining | PubMed |
| Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model. | Front Oncol | 2023 | 37397378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=16